Table:
begin	end	state
1	25	signal peptide
26	33	non-cytoplasmic
34	55	transmembrane
56	61	cytoplasmic
62	80	transmembrane
81	85	non-cytoplasmic
86	107	transmembrane
108	113	cytoplasmic
114	132	transmembrane
133	161	non-cytoplasmic
162	181	transmembrane
182	206	cytoplasmic
207	228	transmembrane
229	247	non-cytoplasmic
248	273	transmembrane
274	289	cytoplasmic
290	308	transmembrane
309	594	non-cytoplasmic

Input:
>WP_012402388.1 NCBI__GCF_000020045.1:WP_012402388.1
MNRIMKNKLFWLFLVVMFALPVLPQPIRVPEYWVTLLNYIGLYSIVAIGLVLLTGIGGMT
SFGQAAFVGVGAYTTAYLTTQLGVSPWLALIAGVVLTALIALLLGAVTMRLSGHFLPLGT
IAWGLALFFLFGNMEMLGKYDGINGIPVLNVLGVNLESGRHIYYLIWIVVLGAVVSVQNL
LNSRPGRAIRALRGGGLMAEAMGVNTAWMRVVIFVYAAVLAAISGFLYAHLQRAVNPTPF
GLNHGIEFLFMAVVGGVAHVWGAVLGAAILTVLQDYLQTLLPKLLGENGNFEIIVFGILM
VLLLQYARQGVWPFVARSFPRGPRAHVPDHADALPQRSKPATGEPLLVVDKARKQFGGLV
AVNDVSFEVKAGQIIGLIGPNGAGKSTTFNLVTGVLQATSGAITFRGERIDALNSREIVK
RGIGRTFQHVKLLPGMTVLENVAIGGHLRGRAGVWRSVARLNGAEEGRLMAEAARQIRRV
GLEEHMYDEAGSLALGKQRILEIARALCCDPTLLLLDEPAAGLRYQEKQQLATLLRKLRE
EGMSLLLVEHDMDFVMNLTDRLVVMEFGTRIAEGLPQDVQNDPAVLEAYLGGVE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server